 |
At the core of Nutrition 21, lies the belief that high quality science and ground-breaking technology can lead to the development of superior products. The company’s scientific platform is based upon our ability to create patentable products that have enhanced absorption and bioavailability to produce safe and clinically efficacious results.
Learn
More
Nutrition 21, Inc.
4 Manhattanville Road
Purchase, NY 10577
Phone: 914-701-4500
|
|
|
 |
Leveraging its biotechnology heritage, Nutrition
21 is pioneering an effort to use patented technology,
pharmaceutical research and strategic marketing and distribution
partnerships to build its position in therapeutic markets. The
Company is targeting specific disease states and age related
health care concerns through its patented and proprietary
ingredients. The disease states and therapeutic areas include
obesity/pre-diabetes, metabolic syndrome, diabetes,
cardiovascular health, arthritis, mood disorders, cognitive
function, digestive health, and immune system health.
Nutrition 21 relies on well designed preclinical and clinical
trials as key elements of its discovery, product development,
and marketing strategies. The Company’s objective is to
translate its scientific findings into trusted brands recognized
for their measurable contribution to improving health and
reducing cost of care. The Company earns the trust of consumers
with endorsements from healthcare professionals and by getting
our products adopted as a standard therapy recommended by
doctors and health care professionals.
Different from most biotechnology or pharmaceutical companies,
the Company is primarily focused on developing products that are
marketed under the Dietary Supplement Health and Education Act
(DSHEA) regulatory pathway. The Food and Drug Administration’s
(FDA) regulations for the supplement category enable companies
to bring products to market in less time and with less cost than
is required for FDA drug approval. Different from most
nutritional supplement companies, clinical substantiation is a
requirement for our product development program.
Armed with clinical evidence that promises to reveal remarkable,
clinically measurable effects of its products in therapeutic
approaches to epidemic diseases, Nutrition 21 enjoys the
following unique competitive advantages:
• An established base business that supports a robust clinical
research and business development effort;
• An expertise in identifying and patenting nutrition therapies
addressing overlapping health markets that affect as many as 75
percent of US adults;
• A history of successfully patenting its innovations and
enforcing its patents;
• Research alliances with leading universities, research
institutes and scientists;
• A proven track record in leveraging clinical outcomes to build
consumer and trade awareness for its nutrition products through
public relations;
• Close working relationships with many of the major nutritional
product marketers and manufacturers, and finished product
retailers in the US;
• A robust product development pipeline
Nutrition 21 is fully committed to the responsible marketing of
dietary supplements. The company not only uses pharmaceutical
research standards to establish the safety and efficacy of the
products it markets, but also maintains that commitment through
a rigorous manufacturing and quality assurance programs.
|
|
 |
|
|
|
